Danish firm launches cryotherapy venture in US following FDA approval
Portable cryotherapy Hydrozid is now being launched in the US. A sales partner has been found.
by mikkel aabenhus hemmingsen, translated by catherine brett
A brand new FDA approval means Medilink can launch Hydrozid on the world's largest markets for pharmaceutical and medtech products.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA rejects Takeda/Shire candidate
For subscribers
